Neurological Biomarkers Market Covers the Leading Key Players: DiaGenic ASA, Abbott, Quanterix
๐๐ก๐ ๐ซ๐๐๐๐ง๐ญ๐ฅ๐ฒ ๐ฉ๐ฎ๐๐ฅ๐ข๐ฌ๐ก๐๐ ๐๐๐ฎ๐ซ๐จ๐ฅ๐จ๐ ๐ข๐๐๐ฅ ๐๐ข๐จ๐ฆ๐๐ซ๐ค๐๐ซ๐ฌ ๐๐๐ซ๐ค๐๐ญ ๐ฌ๐ญ๐ฎ๐๐ฒ ๐ซ๐๐ฉ๐จ๐ซ๐ญ ๐๐ฒ ๐๐จ๐ฅ๐๐ซ๐ข๐ฌ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฌ๐๐๐ซ๐๐ก ๐ซ๐๐ฏ๐๐๐ฅ๐ฌ ๐ญ๐ก๐๐ญ ๐ญ๐ก๐ ๐ ๐ฅ๐จ๐๐๐ฅ ๐ง๐๐ฎ๐ซ๐จ๐ฅ๐จ๐ ๐ข๐๐๐ฅ ๐๐ข๐จ๐ฆ๐๐ซ๐ค๐๐ซ๐ฌ ๐ฆ๐๐ซ๐ค๐๐ญ ๐ฐ๐๐ฌ ๐๐๐ ๐.๐๐ ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐ข๐ง ๐๐๐๐, ๐ฐ๐ข๐ญ๐ก ๐ ๐๐๐๐ ๐จ๐ ๐๐.๐๐% ๐ฉ๐ซ๐จ๐ฃ๐๐๐ญ๐๐ ๐๐ซ๐จ๐ฆ ๐๐๐๐ ๐ญ๐จ ๐๐๐๐.๐๐ก๐ ๐ ๐ฅ๐จ๐๐๐ฅ ๐ง๐๐ฎ๐ซ๐จ๐ฅ๐จ๐ ๐ข๐๐๐ฅ ๐๐ข๐จ๐ฆ๐๐ซ๐ค๐๐ซ๐ฌ ๐ฆ๐๐ซ๐ค๐๐ญ ๐ข๐ฌ ๐๐ฑ๐ฉ๐๐๐ญ๐๐ ๐ญ๐จ ๐จ๐๐๐๐ซ ๐๐ง ๐๐๐ฌ๐จ๐ฅ๐ฎ๐ญ๐ ๐จ๐ฉ๐ฉ๐จ๐ซ๐ญ๐ฎ๐ง๐ข๐ญ๐ฒ ๐จ๐ ๐๐๐ ๐๐.๐๐ ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐๐ฒ ๐๐๐๐.
The need for neurological biomarkers has grown as a result of the growing existence of neurological illnesses involving conditions such as migraine, dementia, Alzheimer's disease, brain tumors, epilepsy, and others is confident of driving market augmentation. For instance, as per WHO, epilepsy causes roughly 13 million impairments calibrated life cycle and accounts for more than 0.5% of the global disease loads.
๐๐๐ญ ๐๐ฑ๐๐ฅ๐ฎ๐ฌ๐ข๐ฏ๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ ๐๐ฌ ๐จ๐ ๐๐ก๐ข๐ฌ ๐๐๐ฉ๐จ๐ซ๐ญ:
https://www.polarismarketresearch.com/industry-analysis/neurological-biomarkers-market/request-for-sample
Lately, biomarkers have been increasingly embraced in clinical patterns and clinical attempts in the area of neurology. The tempo of detection has been speeding due to technological progressions with escalated accuracy and susceptibility of the instrument and assays and cross-fertilization from one area of neurology to another. The weapons of biomarkers in neurology are prone to continue growing as the potential to estimate precisely manifold biological dynamics and knowhow about the pathophysiology of neurological illnesses escalate. They are utilized for many causes, to steer clinical diagnosis, to approximate illness probability or prognosis, to gauge illness phase, and to observe advancement or answer to therapy.
๐๐จ๐ฆ๐ฉ๐๐ง๐ข๐๐ฌ ๐๐จ๐ฏ๐๐ซ๐๐
The market is portrayed by fierce contention, with entrenched players depending on progressive technology, elevated standard commodities, and a robust brand image to push revenue growth.
๐๐จ๐ฆ๐ ๐จ๐ ๐ญ๐ก๐ ๐๐จ๐ฆ๐ฉ๐๐ง๐ข๐๐ฌ ๐ฐ๐ก๐ข๐๐ก ๐๐ซ๐ ๐๐ฎ๐ซ๐ซ๐๐ง๐ญ๐ฅ๐ฒ ๐๐จ๐ฆ๐ข๐ง๐๐ญ๐ข๐ง๐ ๐ญ๐ก๐ ๐ง๐๐ฎ๐ซ๐จ๐ฅ๐จ๐ ๐ข๐๐๐ฅ ๐๐ข๐จ๐ฆ๐๐ซ๐ค๐๐ซ๐ฌ ๐ฆ๐๐ซ๐ค๐๐ญ ๐๐ซ๐:
โข Abbott
โข Alseres Pharmaceuticals, Inc.
โข BANYAN BIOMARKERS, INC.
โข Bio-Rad Laboratories, Inc.
โข DiaGenic ASA
โข Johnson & Johnson Services, Inc.
โข Merck & Co., Inc.
โข Myriad Genetics, Inc.
โข Quanterix
โข Thermo Fisher Scientific, Inc.
๐๐ฎ๐ฒ ๐๐จ๐ฐ ๐๐ก๐ข๐ฌ ๐๐ซ๐๐ฆ๐ข๐ฎ๐ฆ ๐๐๐ฌ๐๐๐ซ๐๐ก ๐๐๐ฉ๐จ๐ซ๐ญ๐ฌ:
https://www.polarismarketresearch.com/buy/2965/0
๐๐๐ฒ ๐๐๐ค๐๐๐ฐ๐๐ฒ๐ฌ ๐๐ซ๐จ๐ฆ ๐ญ๐ก๐ ๐๐๐ฉ๐จ๐ซ๐ญ
โข The primary factors propelling the market growth of neurological biomarkers are blood-based biomarkers, playing an important part in choosing relevant remedies and observing disease advancement.
โข The neurological biomarkers market analysis is mainly based on type, application, end-use, and region.
โข North America dominated the market.
โข The market in Asia Pacific will increase as a result of the growth of clinical trials in surfacing nations such as China and India and a growing illness weight.
๐๐๐ ๐ฆ๐๐ง๐ญ๐๐ฅ ๐๐ฏ๐๐ซ๐ฏ๐ข๐๐ฐ
๐๐ก๐ ๐ฆ๐๐ซ๐ค๐๐ญ ๐ข๐ฌ ๐ฉ๐ซ๐ข๐ฆ๐๐ซ๐ข๐ฅ๐ฒ ๐ฌ๐๐ ๐ฆ๐๐ง๐ญ๐๐ ๐๐๐ฌ๐๐ ๐จ๐ง ๐ญ๐ฒ๐ฉ๐, ๐๐ฉ๐ฉ๐ฅ๐ข๐๐๐ญ๐ข๐จ๐ง, ๐๐ง๐-๐ฎ๐ฌ๐, ๐๐ง๐ ๐ซ๐๐ ๐ข๐จ๐ง.
๐๐ฒ ๐๐ฒ๐ฉ๐
โข Metabolomic
โข Genomic
โข Imaging
โข Proteomic
โข Others
๐๐ฒ ๐๐ฉ๐ฉ๐ฅ๐ข๐๐๐ญ๐ข๐จ๐ง
โข Autism Spectrum Disorder
โข Parkinson's Disease
โข Alzheimer's Disease
โข Multiple Sclerosis
โข Others
๐๐ฒ ๐๐ง๐ ๐๐ฌ๐
โข Independent clinical diagnostic centers
โข Research Organizations and Others
โข Hospital & Hospital Laboratories
๐๐ฒ ๐๐๐ ๐ข๐จ๐ง
โข North America (U.S., Canada)
โข Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia)
โข Asia Pacific (Japan, China, India, Malaysia, Indonesia, South Korea)
โข Latin America (Brazil, Mexico, Argentina)
โข Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)
๐๐จ๐ฉ ๐๐ข๐ ๐ก๐ฅ๐ข๐ ๐ก๐ญ๐ฌ ๐จ๐ ๐๐๐ฉ๐จ๐ซ๐ญ:
โข Offers a thorough analysis of neurological biomarkers market covering all the major aspects.
โข Provides an estimation of the current, historical, and projected market size in terms of volume and value.
โข Includes a detailed market segmentation covering all the major segments and sub-segments.
โข An examination of the top market trends and developments has been provided in the report.
โข Assesses the strategies of key market players and their product offerings.
โข The study analyzes the changing market dynamics and classifies new partners or clients in the target demographic.
๐๐ฅ๐ข๐๐ค ๐ก๐๐ซ๐ ๐ญ๐จ ๐๐๐๐๐ฌ๐ฌ ๐ญ๐ก๐ ๐ ๐ฎ๐ฅ๐ฅ ๐๐๐ฉ๐จ๐ซ๐ญ:
https://www.polarismarketresearch.com/industry-analysis/neurological-biomarkers-market
๐๐๐ฒ ๐๐ฎ๐๐ฌ๐ญ๐ข๐จ๐ง๐ฌ ๐๐ง๐ฌ๐ฐ๐๐ซ๐๐ ๐ข๐ง ๐ญ๐ก๐ ๐๐๐ฉ๐จ๐ซ๐ญ:
โข What is the current neurological biomarkers market size and forecast value?
โข Who are the key players in the market?
โข What are the opportunities and challenges market players might encounter?
โข What are the key trends driving the market growth?
โข At what CAGR is the market anticipated to grow?
โข What is the estimated demand for different types of products/services in the market?
๐๐๐ฅ๐๐ญ๐๐ ๐๐๐ฉ๐จ๐ซ๐ญ:
๐๐ฑ๐ข๐๐๐ญ๐ข๐ฏ๐ ๐๐ญ๐ซ๐๐ฌ๐ฌ ๐๐ฌ๐ฌ๐๐ฒ ๐๐๐ซ๐ค๐๐ญ
https://www.polarismarketresearch.com/industry-analysis/oxidative-stress-assay-market
๐๐๐ ๐ฎ๐ฅ๐๐ญ๐จ๐ซ๐ฒ ๐๐ง๐๐จ๐ซ๐ฆ๐๐ญ๐ข๐จ๐ง ๐๐๐ง๐๐ ๐๐ฆ๐๐ง๐ญ ๐๐ฒ๐ฌ๐ญ๐๐ฆ ๐๐๐ซ๐ค๐๐ญ
https://www.polarismarketresearch.com/industry-analysis/regulatory-information-management-system-market
๐.๐. ๐๐ข๐๐๐๐ญ๐๐ฌ ๐๐๐ฏ๐ข๐๐๐ฌ ๐๐๐ซ๐ค๐๐ญ
https://www.polarismarketresearch.com/industry-analysis/us-diabetes-devices-market
๐๐ฅ๐ฅ๐๐ซ๐ ๐ฒ ๐๐ข๐๐ ๐ง๐จ๐ฌ๐ญ๐ข๐๐ฌ ๐๐๐ซ๐ค๐๐ญ
https://www.polarismarketresearch.com/industry-analysis/allergy-diagnostics-market
๐๐ฅ๐ฎ๐๐จ๐ฌ๐ ๐๐ข๐จ๐ฌ๐๐ง๐ฌ๐จ๐ซ ๐๐๐ซ๐ค๐๐ญ
https://www.polarismarketresearch.com/industry-analysis/glucose-biosensors-market
๐๐จ๐ง๐ญ๐๐๐ญ:
๐๐ข๐ค๐ก๐ข๐ฅ ๐
8 The Green Ste 19824,
Dover, DE 19901,
United States
๐๐ก๐จ๐ง๐:+1-929 297-9727
๐๐ฆ๐๐ข๐ฅ: sales@polarismarketresearch.com
๐๐๐: https://www.polarismarketresearch.com
๐ ๐จ๐ฅ๐ฅ๐จ๐ฐ ๐๐ฌ: LinkedIn | Twitter
๐๐๐จ๐ฎ๐ญ ๐๐จ๐ฅ๐๐ซ๐ข๐ฌ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฌ๐๐๐ซ๐๐ก & ๐๐จ๐ง๐ฌ๐ฎ๐ฅ๐ญ๐ข๐ง๐ , ๐๐ง๐:
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR's clientele spread across different enterprises. We at Polaris are obliged to serve PMR's diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR's customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR's customers.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Neurological Biomarkers Market Covers the Leading Key Players: DiaGenic ASA, Abbott, Quanterix here
News-ID: 3666777 • Views: โฆ
More Releases from Polaris Market Research & Consulting
IoT Medical Devices Market 2024 Top Manufacturers are: Abbott Laboratories, Aliv โฆ
๐๐จ๐ ๐๐๐๐ข๐๐๐ฅ ๐๐๐ฏ๐ข๐๐๐ฌ-๐๐๐ซ๐ค๐๐ญ ๐๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ, ๐๐ข๐ณ๐ ๐๐๐ฏ๐๐ง๐ฎ๐, ๐๐ฎ๐ญ๐ฅ๐จ๐จ๐ค, ๐๐ฏ๐๐ซ๐ฏ๐ข๐๐ฐ, ๐๐ง๐ ๐๐ง๐๐ฅ๐ฒ๐ฌ๐ข๐ฌ. ๐๐ก๐ ๐ ๐ฅ๐จ๐๐๐ฅ ๐๐จ๐ ๐ฆ๐๐๐ข๐๐๐ฅ ๐๐๐ฏ๐ข๐๐๐ฌ ๐ฆ๐๐ซ๐ค๐๐ญ ๐ฐ๐๐ฌ ๐๐ฌ๐ญ๐ข๐ฆ๐๐ญ๐๐ ๐ญ๐จ ๐๐ ๐ฐ๐จ๐ซ๐ญ๐ก ๐๐๐ ๐๐.๐๐ ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐ข๐ง ๐๐๐๐ ๐๐ง๐ ๐ข๐ฌ ๐ฉ๐ซ๐๐๐ข๐๐ญ๐๐ ๐ญ๐จ ๐๐ฑ๐ฉ๐๐ง๐ ๐ญ๐จ ๐๐๐ ๐๐๐.๐๐ ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐๐ฒ ๐๐๐๐, ๐ฐ๐ข๐ญ๐ก ๐ ๐๐๐๐ ๐จ๐ ๐๐.๐๐% ๐๐ซ๐จ๐ฆ ๐๐๐๐ ๐ญ๐จ ๐๐๐๐.
๐๐๐ฉ๐จ๐ซ๐ญ ๐๐๐จ๐ฉ๐:
This comprehensive study provides an accurate overview of the worldwide IoT medical devices market. Comprehensive analyses of sales volume, price, revenue, market share, andโฆ
Intelligent Power Module Market is Predicted to Expand to 7.71 Billion with a CA โฆ
An integrated power module, or IPM, is a module containing different power electronics components like power switches, gate drivers, and protection circuits. IPMs are designed to offer effective supervision and management for high-power applications by including functions like overcurrent protection, thermal regulation, and advanced control algorithms, allowing them to be utilized in motor controls, renewable energy setups, and industrial automation. IPMs are small, dependable, and provide effective power management, makingโฆ
Cybersecurity Insurance Market to Witness Impressive Expansion of USD 48.83 Bill โฆ
Cybersecurity Insurance Market Insights, Size Revenue, Outlook, Overview, and Analysis. The global cybersecurity insurance market was estimated to be worth USD 10.13 billion in 2021 and is predicted to expand to USD 48.83 billion by 2030, with a CAGR of 19.29% from 2022 to 2030.
๐๐๐ฉ๐จ๐ซ๐ญ ๐๐๐จ๐ฉ๐:
This comprehensive study provides an accurate overview of the worldwide cybersecurity insurance market. Comprehensive analyses of sales volume, price, revenue, market share, and importantโฆ
With 17.7% CAGR, Cold Chain Monitoring Market Size Value To Reach USD 25,963.49 โฆ
The cold chain monitoring market size was valued at USD 5,284.14 million in 2022. The market is projected to grow to USD 25,963.49 million by 2032, exhibiting a compound annual growth rate (CAGR) of 17.7% from 2023 to 2032.
๐๐๐ซ๐ค๐๐ญ ๐๐๐๐ข๐ง๐ข๐ญ๐ข๐จ๐ง:
Cold chain monitoring is an intricate supply system that makes use of IoT technology to supervise perishable items such as vaccines, chemicals, and pharmaceutical products that need precise temperature regulation.โฆ
More Releases for Neurological
Neurological Disorder Drugs Market - Forecasts to 2027
According to a new market research report published by Global Market Estimates, the Global Neurological Disorder Drugs Market is projected to grow at a CAGR value of 5.6% from 2022 to 2027. The rising cases of neurodegenerative diseases such as dementia and Alzheimer's disease, a susceptible aging population, and an increase in research and development projects by numerous pharmaceutical companies are factors fueling market growth during the forecast period.
Pfizer Inc,โฆ
Neurological Biomarkers Market 2021 | Detailed Report
ReportsnReports publishes the report titled Neurological Biomarkers that presents a 360-degree overview of the market under one roof. The report is developed with the meticulous efforts of an enthusiastic and experienced team of experts, analyts, and researchers that makes the report a valuable asset for stakeholders to make robust decisions. This report also provides an in-depth overview of product type, specification, technology, and production analysis considering vital factors like cost,โฆ
Global Neurological Biomarkers Market - Forecast to 2026
The findings reviewed by GME stated that the Global Neurological Biomarkers Market would grow at a CAGR value of 10.2 percent from 2021 to 2026. Today, with advancing technology and neurological applications, the awareness about the effectiveness of biomarker signature in diagnosing diseases or disorders is also increasing. Besides the beneficial features attributed to the neurological biomarkers, the annual exponential increase in the rate of neurological diseases is also acceleratingโฆ
7th International Conference on Neurological Disorders & Stroke
Greetings from Stroke Congress 2018!!
We are writing to request all your presence to our CME accredited event as our eminent Speaker for the upcoming โ7th International Conference on Neurological Disorders & Stroke (Stroke Congress 2018)โ scheduled to be held on September 20-21, 2018 in Rome, Italy.
The theme of the conference is Melioration in Innovations with advancement in Neurological disorders and Stroke to create awareness on the current needs &โฆ
Neurological Biomarkers Market Competition Insights 2025
Global Neurological Biomarkers Market: Overview
This report on the global neurological biomarkers market is a comprehensive market intelligence study that brings forth the lucrativeness of the said market. Beginning with an executive summary that comprise a snapshot of how the demand for neurological biomarkers has evolved over the recent past and where is it headed to in the future, the report delves into the analysis of various market dynamics, such asโฆ
Neurological Biomarkers Market: Pipeline Overview 2017 - 2025
Biomarkers are biological markers which measure the biological states. It is used for indicating the normal biological and pathogenic process to a therapeutic intervention. These biomarkers can also be used in combination to access disease state of an individual. Scientists are exploring more about the structural and functional differences of the neurological diseases. Moreover, there has been an increase in biobanks which have help address unmet needs in oncology, neuroscience,โฆ